CAMURUS Trademark
Trademark Overview
On Thursday, June 30, 2022, a trademark application was filed for CAMURUS with the United States Patent and Trademark Office. The USPTO has given the CAMURUS trademark a serial number of 97483616. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Monday, April 15, 2024. This trademark is owned by Camurus AB. The CAMURUS trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations and substances for the treatment of genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal, cognitive, and substance abuse related diseases and disorders; subcutaneous drug delivery agents sold as a component of pharmaceutical preparations for the treatment of genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal, cognitive, and substance abuse related diseases and disorders; drug delivery agents in the form of subcutaneous compounds that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; sustained or extended release drug delivery agents sold as a component of pharmaceutical preparations for the treatment of genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal, cognitive, and substance abuse related diseases and disorders; drug delivery agents in the f...
General Information
| Serial Number | 97483616 |
| Word Mark | CAMURUS |
| Filing Date | Thursday, June 30, 2022 |
| Status | 731 - SECOND EXTENSION - GRANTED |
| Status Date | Monday, April 15, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 21, 2023 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations and substances for the treatment of genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal, cognitive, and substance abuse related diseases and disorders; subcutaneous drug delivery agents sold as a component of pharmaceutical preparations for the treatment of genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal, cognitive, and substance abuse related diseases and disorders; drug delivery agents in the form of subcutaneous compounds that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; sustained or extended release drug delivery agents sold as a component of pharmaceutical preparations for the treatment of genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal, cognitive, and substance abuse related diseases and disorders; drug delivery agents in the form of sustained or extended release drug delivery compounds that provide sustained or extended release of the active ingredients for a wide variety of pharmaceuticals; lipid-based drug delivery agents sold as a component of pharmaceutical preparations for the treatment of genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal, cognitive, and substance abuse related diseases and disorders administered via subcutaneous injection; veterinary vaccines; sanitary preparations for medical use; dietetic foods adapted for medical use; food for babies; dietary supplements for human beings and animals; medical plasters; gauze and bandages for dressings; teeth filling material; dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, July 20, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Camurus AB |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Lund 22370
SE |
| Party Name | Camurus AB |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Lund 22370
SE |
Trademark Events
| Event Date | Event Description |
| Monday, July 4, 2022 | NEW APPLICATION ENTERED |
| Wednesday, July 20, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, February 15, 2023 | ASSIGNED TO EXAMINER |
| Wednesday, February 15, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, March 1, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, March 21, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, March 21, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 16, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Wednesday, October 25, 2023 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, October 25, 2023 | SOU EXTENSION 1 FILED |
| Wednesday, October 25, 2023 | SOU EXTENSION 1 GRANTED |
| Friday, October 27, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, April 15, 2024 | SOU TEAS EXTENSION RECEIVED |
| Monday, April 15, 2024 | SOU EXTENSION 2 FILED |
| Monday, April 15, 2024 | SOU EXTENSION 2 GRANTED |
| Tuesday, April 16, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, November 14, 2024 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, December 4, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, December 4, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, December 4, 2024 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Wednesday, December 4, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Wednesday, December 4, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, December 4, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
